GFAP and Parkinson disease: Other mechanisms suggested in the literature for the neuroprotective effects of muscimol include ROS scavenging; influence of the metabolism at the mitochondrial level; GSH preservation; reducing glial fibrillary acidic protein (GFAP) expressions, which is pivotal in Parkinson’s disease (PD) [36,37].